Preemptive use of lamivudine in breast cancer patients carrying hepatitis B virus undergoing cytotoxic chemotherapy: a longitudinal follow-up

Author： Dai Ming-Shen

Publisher： Springer Publishing Company

ISSN： 0941-4355

Source： Supportive Care in Cancer, Vol.12, Iss.3, 2004-03, pp. : 191-196

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of lamivudine to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patients

By Yeo Winnie

Breast Cancer Research and Treatment, Vol. 88, Iss. 3, 2004-12 ,pp. : 209-215

Springer Publishing Company

Access to resources Recommend Favorite

Hepatitis B Virus Reactivation in Patients Receiving Chemotherapy for Cancer Treatment: Role of Lamivudine Prophylaxis

By Coiffier Bertrand

Cancer Investigation, Vol. 24, Iss. 5, 2006-06 ,pp. : 548-552

Informa Healthcare

Access to resources Recommend Favorite

The Clinical Outcome of Chemotherapy-Induced Amenorrhea in Premenopausal Young Patients with Breast Cancer with Long-Term Follow-up

By Jung Minkyu

Annals of Surgical Oncology, Vol. 17, Iss. 12, 2010-12 ,pp. : 3259-3268

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Utility of Serial Serum c-erbB-2 Determinations in the Follow-up of Breast Cancer Patients

By Fehm T. Gebauer G. Jäger W.

Breast Cancer Research and Treatment, Vol. 75, Iss. 2, 2002-09 ,pp. : 97-106

Springer Publishing Company

Access to resources Recommend Favorite

Long-term follow-up of the Stockholm randomized trials of postoperative radiation therapy versus adjuvant chemotherapy among ‘high risk' pre- and postmenopausal breast cancer patients

By Rutqvist Lars Johansson Hemming

Acta Oncologica, Vol. 45, Iss. 5, 2006-07 ,pp. : 517-527

Informa Healthcare

Access to resources Recommend Favorite